- Home
- EDSA vs MTEX Comparison
EDSA vs MTEX Comparison
Compare EDSA & MTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- MTEX
- Stock Information
- Founded
- EDSA 2015
- MTEX 1993
- Country
- EDSA Canada
- MTEX United States
- Employees
- EDSA N/A
- MTEX N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- MTEX Medicinal Chemicals and Botanical Products
- Sector
- EDSA Health Care
- MTEX Health Care
- Exchange
- EDSA Nasdaq
- MTEX Nasdaq
- Market Cap
- EDSA 6.0M
- MTEX 23.0M
- IPO Year
- EDSA N/A
- MTEX 1999
- Fundamental
- Price
- EDSA $1.82
- MTEX $11.92
- Analyst Decision
- EDSA Strong Buy
- MTEX
- Analyst Count
- EDSA 1
- MTEX 0
- Target Price
- EDSA $21.00
- MTEX N/A
- AVG Volume (30 Days)
- EDSA 31.5K
- MTEX 6.4K
- Earning Date
- EDSA 12-13-2024
- MTEX 11-12-2024
- Dividend Yield
- EDSA N/A
- MTEX N/A
- EPS Growth
- EDSA N/A
- MTEX N/A
- EPS
- EDSA N/A
- MTEX N/A
- Revenue
- EDSA N/A
- MTEX $121,552,000.00
- Revenue This Year
- EDSA N/A
- MTEX N/A
- Revenue Next Year
- EDSA N/A
- MTEX N/A
- P/E Ratio
- EDSA N/A
- MTEX N/A
- Revenue Growth
- EDSA N/A
- MTEX N/A
- 52 Week Low
- EDSA $1.55
- MTEX $6.75
- 52 Week High
- EDSA $5.99
- MTEX $13.00
- Technical
- Relative Strength Index (RSI)
- EDSA 35.86
- MTEX 57.73
- Support Level
- EDSA $1.55
- MTEX $9.74
- Resistance Level
- EDSA $1.91
- MTEX $11.62
- Average True Range (ATR)
- EDSA 0.14
- MTEX 0.78
- MACD
- EDSA 0.04
- MTEX -0.15
- Stochastic Oscillator
- EDSA 49.07
- MTEX 56.13
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.